Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Merck KGaA    MRK   DE0006599905

MERCK KGAA

(MRK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

11/23/2020 | 04:16am EST

DGAP Voting Rights Announcement: Merck KGaA
Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

23.11.2020 / 10:15
Dissemination of a Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Notification of Major Holdings

1. Details of issuer
Name: Merck KGaA
Street: Frankfurter Str. 250
Postal code: 64293
City: Darmstadt
Germany
Legal Entity Identifier (LEI): 529900OAREIS0MOPTW25

2. Reason for notification
X Acquisition/disposal of shares with voting rights
  Acquisition/disposal of instruments
  Change of breakdown of voting rights
  Other reason:

3. Details of person subject to the notification obligation
Natural person (first name, surname): George Loening
Date of birth: 30 Jan 1966

4. Names of shareholder(s)
holding directly 3% or more voting rights, if different from 3.
 

5. Date on which threshold was crossed or reached:
13 Nov 2020

6. Total positions
  % of voting rights attached to shares
(total of 7.a.)
% of voting rights through instruments
(total of 7.b.1 + 7.b.2)
Total of both in %
(7.a. + 7.b.)
Total number of voting rights pursuant to Sec. 41 WpHG
New 2.97 % 0.02 % 2.99 % 129242252
Previous notification 3.11 % 0.04 % 3.15 % /

7. Details on total positions
a. Voting rights attached to shares (Sec. 33, 34 WpHG)
ISIN Absolute In %
  Direct
(Sec. 33 WpHG)
Indirect
(Sec. 34 WpHG)
Direct
(Sec. 33 WpHG)
Indirect
(Sec. 34 WpHG)
DE0006599905 0 3832793 0.00 % 2.97 %
Total 3832793 2.97 %

b.1. Instruments according to Sec. 38 (1) no. 1 WpHG
Type of instrument Expiration or maturity date Exercise or conversion period Voting rights absolute Voting rights in %
0 0.00 %
    Total 0 0.00 %

b.2. Instruments according to Sec. 38 (1) no. 2 WpHG
Type of instrument Expiration or maturity date Exercise or conversion period Cash or physical settlement Voting rights absolute Voting rights in %
CFD n/a n/a Cash 28774 0.02 %
      Total 28774 0.02 %

8. Information in relation to the person subject to the notification obligation
  Person subject to the notification obligation is not controlled nor does it control any other undertaking(s) that directly or indirectly hold(s) an interest in the (underlying) issuer (1.).
X Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:

Name % of voting rights (if at least 3% or more) % of voting rights through instruments (if at least 5% or more) Total of both (if at least 5% or more)
George Loening % % %
Cooper Square Holdings II, LLC % % %
Cooper Square Fund II, L.P. % % %
- % % %
George Loening % % %
Cooper Square Holdings, LLC % % %
Cooper Square Fund, L.P. % % %
- % % %
George Loening % % %
Baxter Street Holdings, LLC % % %
Baxter Street Fund, L.P. % % %
- % % %
George Loening % % %
Baxter Street Holdings II, LLC % % %
Baxter Street Fund II, L.P. % % %
- % % %
George Loening % % %
SEG Partners Holdings, LLC % % %
SEG Partners Fund, L.P. % % %
- % % %
George Loening % % %
SEG Partners II Holdings, LLC % % %
SEG Partners Fund II, L.P. % % %
- % % %
George Loening % % %
SEG Blackwall Holdings, LLC % % %
SEG Blackwall Fund, L.P. % % %
- % % %
George Loening % % %
Select Equity GP, LLC % % %
Select Equity Group L.P. % % %

9. In case of proxy voting according to Sec. 34 para. 3 WpHG
(only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG)

Date of general meeting:
Holding total positions after general meeting (6.) after annual general meeting:
Proportion of voting rights Proportion of instruments Total of both
% % %

10. Other explanatory remarks:
 

Date
19 Nov 2020



23.11.2020 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Merck KGaA
Frankfurter Str. 250
64293 Darmstadt
Germany
Internet: https://www.merckgroup.com/de

 
End of News DGAP News Service

1149817  23.11.2020 

fncls.ssp?fn=show_t_gif&application_id=1149817&application_name=news&site_id=zonebourse_sftp

© EQS 2020
All news about MERCK KGAA
01/26PFIZER : EMD Serono - European Commission Approves BAVENCIO for First-Line Maint..
AQ
01/25MERCK KGAA : DZ Bank gives a Buy rating
MD
01/25PFIZER : Germany's Merck Secure European Commission Approval for Bladder Cancer ..
MT
01/25European Commission Authorizes Use Of Merck-Pfizer Cancer Drug Bavencio
MT
01/22MERCK KGAA : Independant Research sticks Neutral
MD
01/22MERCK KGAA : Barclays reaffirms its Neutral rating
MD
01/21MERCK KGAA : Kepler Cheuvreux remains its Buy rating
MD
01/21MERCK KGAA : Bernstein remains Neutral
MD
01/21MERCK KGAA : JP Morgan maintains a Buy rating
MD
01/21MERCK KGAA : UBS reaffirms its Neutral rating
MD
More news
Financials
Sales 2020 17 362 M 20 989 M 20 989 M
Net income 2020 1 977 M 2 390 M 2 390 M
Net Debt 2020 11 147 M 13 475 M 13 475 M
P/E ratio 2020 30,2x
Yield 2020 1,02%
Capitalization 59 891 M 72 445 M 72 400 M
EV / Sales 2020 4,09x
EV / Sales 2021 3,80x
Nbr of Employees 58 077
Free-Float 29,7%
Chart MERCK KGAA
Duration : Period :
Merck KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MERCK KGAA
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 139,28 €
Last Close Price 137,75 €
Spread / Highest target 22,7%
Spread / Average Target 1,11%
Spread / Lowest Target -26,7%
EPS Revisions
Managers and Directors
NameTitle
Stefan Oschmann Chairman-Executive Board & CEO
Wolfgang Heinz Büchele Chairman-Supervisory Board
Marcus Kuhnert Chief Financial Officer
Christian Raabe Independent Member-Supervisory Board
Edeltraud Glänzer Independent Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
MERCK KGAA-1.85%72 445
ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD15.70%27 725
KYOWA KIRIN CO., LTD.3.70%15 327
BETTA PHARMACEUTICALS CO., LTD.32.16%8 638
YUHAN CORPORATION-3.06%4 217
RECIPHARM AB (PUBL)3.92%2 772